Pressrelease – Lund, November 9th, 2026 – Hamlet BioPharma presented at the BioStock Life Science Summit on November 5, 2026

Hamlet BioPharma AB announces that the company presented its latest progress at the BioStock Life Science Summit on November 5, 2026.

BioStock is an information platform serving both the life science industry and the investment community, providing accessible industry news and in-depth company insights, alongside reliable data and market analysis for the entire sector.

Watch the presentation here: https://biostock.se/en/2026/11/hamlet-biopharma-life-science-summit-2026/

For further information, please contact

Catharina Svanborg, Chairman, Hamlet BioPharma AB, +46 709 42 65 49,

catharina.svanborg@hamletpharma.com

Jakob Testad, CEO, Hamlet BioPharma AB, +46 708 48 42 10,

jakob.testad@hamletbiopharma.com

www.hamletbiopharma.com